These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25552550)

  • 1. Reply to Wang and Zhang.
    Bastos ML; Menzies D;
    Clin Infect Dis; 2015 Apr; 60(8):1286-7. PubMed ID: 25552550
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of drug susceptibility testing results for first- and second-line drugs with treatment outcomes in patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Hong-min W; Xiao-Hong Z
    Clin Infect Dis; 2015 Apr; 60(8):1285-6. PubMed ID: 25552551
    [No Abstract]   [Full Text] [Related]  

  • 3. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
    Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
    Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of drug-resistant TB with individualised DST--the way forward?
    Singhal T; Gupta N
    J Assoc Physicians India; 2014 Jul; 62(7):561-3. PubMed ID: 25672025
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the revised definition of extensively drug-resistant tuberculosis.
    Veziris N; Bonnet I; Morel F; Guglielmetti L; Maitre T; Fournier Le Ray L; Sougakoff W; Robert J; Aubry A; ;
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33926973
    [No Abstract]   [Full Text] [Related]  

  • 6. A Novel Advanced Laboratory Diagnosis to Guide Tuberculosis Drug Therapy.
    Amaral L; van Soolingen D
    Recent Pat Antiinfect Drug Discov; 2015; 10(2):71-3. PubMed ID: 26235217
    [No Abstract]   [Full Text] [Related]  

  • 7. Extensively drug-resistant tuberculosis, Lesotho.
    Satti H; Seung K; Keshavjee S; Furin J
    Emerg Infect Dis; 2008 Jun; 14(6):992-3. PubMed ID: 18551748
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO strategies for the management of drug-resistant tuberculosis.
    Rendon A; Centis R; D'Ambrosio L; Migliori GB
    Arch Bronconeumol; 2017 Mar; 53(3):95-97. PubMed ID: 27717622
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countries.
    Ioannidis P; van Soolingen D; Mokrousov I; Papaventsis D; Karabela S; Konstantinidou E; Marinou I; Nikolaou S; Kanavaki S; Mantadakis E; Samonis G; Anthony R; Vogiatzakis E
    Clin Microbiol Infect; 2017 Dec; 23(12):1002-1004. PubMed ID: 28698038
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug-resistant tuberculosis in India.
    Tageja N; Sharma V
    Lancet; 2010 Aug; 376(9742):682-3. PubMed ID: 20801396
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and Treatment of Drug-Resistant Tuberculosis.
    Caminero JA; Cayla JA; García-García JM; García-Pérez FJ; Palacios JJ; Ruiz-Manzano J
    Arch Bronconeumol; 2017 Sep; 53(9):501-509. PubMed ID: 28359606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis; opportunities for treatment optimization.
    Alffenaar JW
    Curr Pharm Des; 2011; 17(27):2852. PubMed ID: 21834758
    [No Abstract]   [Full Text] [Related]  

  • 15. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 16. The Reductionist Conundrum of an "Updated" Definition of Extensively Drug-Resistant Tuberculosis.
    Mitnick CD; Furin JJ; Hewison C
    Am J Respir Crit Care Med; 2021 Sep; 204(6):629-631. PubMed ID: 34375572
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice?
    Alagna R; Cabibbe AM; Miotto P; Saluzzo F; Köser CU; Niemann S; Gagneux S; Rodrigues C; Rancoita PVM; Cirillo DM
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 34215664
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-resistant tuberculosis plagues India.
    Sibbald B
    CMAJ; 2016 Mar; 188(5):322-324. PubMed ID: 26883311
    [No Abstract]   [Full Text] [Related]  

  • 19. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of revised definitions for extensively drug-resistant TB on disease classification.
    Shin JE; Jo KW; O YJ; Jeon D; Kang H; Yim JJ; Kwon YS; Shim TS
    Int J Tuberc Lung Dis; 2021 Sep; 25(9):766-768. PubMed ID: 34802501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.